Paper43870
Pharmacokinetics of nadolol, a beta-receptor antagonist: administration of therapeutic single- and multiple-dosage regimens to hypertensive patients.
Dreyfuss J and 6 others. J Clin Pharmacol, 1979. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetics of nadolol, a beta-receptor antagonist: administration of therapeutic single- and multiple-dosage regimens to hypertensive patients. Papers, record 43870. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/43870
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacokinetics of nadolol, a beta-receptor antagonist: administration of therapeutic single- and multiple-dosage regimens to hypertensive patients.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic beta-Antagonists | Major topic |
| Hypertension | Major topic |
| Propanolamines | Major topic |
| Biotransformation | |
| Drug Administration Schedule | |
| Humans | |
| Intestinal Absorption | |
| Kinetics | |
| Middle Aged | |
| Time Factors |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41686841 | Effects of matcha green tea on the pharmacokinetics of nadolol in rats. | PLoS One | 2026 | https://conductscience.org/library/papers/41686841 | PubMed |
| 38399480 | A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease and Pediatrics with Supraventricular Tachycardia. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38399480 | PubMed |
| 34112223 | Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup. | Crit Care | 2021 | https://conductscience.org/library/papers/34112223 | PubMed |
| 11422018 | Comparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in man. | Br J Clin Pharmacol | 2001 | https://conductscience.org/library/papers/11422018 | PubMed |
| 8842054 | Bioequivalence of a highly variable drug: an experience with nadolol. | Pharm Res | 1996 | https://conductscience.org/library/papers/8842054 | PubMed |
| 8834196 | Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling of bioavailability data obtained in dogs. | J Pharmacokinet Biopharm | 1995 | https://conductscience.org/library/papers/8834196 | PubMed |
| 6714285 | Pharmacokinetics of nadolol in healthy subjects. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6714285 | PubMed |
| 6124268 | Comparison between atenolol and nadolol in essential hypertension at rest and on exercise. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6124268 | PubMed |
| 6124267 | Nadolol in thyrotoxicosis. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6124267 | PubMed |
| 6117304 | Nadolol in human serum and breast milk. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6117304 | PubMed |
| 6105067 | Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. | Drugs | 1980 | https://conductscience.org/library/papers/6105067 | PubMed |
| 3987783 | Nadolol in combination with indapamide and xipamide in resistant hypertensives. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3987783 | PubMed |
| 3203065 | Penetration of nadolol into aqueous humour after a single oral dose. | Br J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3203065 | PubMed |
| 2235896 | Comparison of single-dose and steady-state nadolol plasma concentrations. | Pharm Res | 1990 | https://conductscience.org/library/papers/2235896 | PubMed |
| 1676675 | A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol. | Eur J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/1676675 | PubMed |
| 1653143 | The effects of chronic dosing on the beta 1 and beta 2-adrenoceptor antagonism of betaxolol and atenolol. | Eur J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/1653143 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/43870
GET https://conductscience.org/api/papers/v1/43870/authors